Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone-targeting macromolecular therapeutics.

Dong Wang1, Scott C Miller, Pavla Kopecková

  • 1Department of Pharmaceutics and Pharmaceutical Chemistry/CCCD, University of Utah, Salt Lake City, UT 84112, USA.

Advanced Drug Delivery Reviews
|May 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrogen bond partner reorganization in the coadsorption of a monodendron and pyridylethynyl derivatives.

Langmuir : the ACS journal of surfaces and colloids·2010
Same author

Pyrolytic hydrocarbon growth from cyclopentadiene.

The journal of physical chemistry. A·2010
Same author

In(III)-catalyzed tandem reaction of chromone-derived Morita-Baylis-Hillman alcohols with amines.

Organic & biomolecular chemistry·2010
Same author

Regression-based multi-trait QTL mapping using a structural equation model.

Statistical applications in genetics and molecular biology·2010
Same author

Elevated expression of APE1/Ref-1 and its regulation on IL-6 and IL-8 in bone marrow stromal cells of multiple myeloma.

Clinical lymphoma, myeloma & leukemia·2010
Same author

Accelerated aging of intervertebral discs in a mouse model of progeria.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2010
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

Novel polymer-based drug delivery systems target bone specifically, reducing toxicity for musculoskeletal diseases like osteoporosis. This approach enhances therapeutic effectiveness by minimizing side effects from non-specific tissue interactions.

Area of Science:

  • Biomaterials Science
  • Pharmacology
  • Orthopedics

Background:

  • Musculoskeletal diseases, including osteoporosis, represent a significant global health burden.
  • Current therapeutic agents often lack specificity for hard tissues, leading to considerable toxicity.
  • There is a need for targeted treatments to improve efficacy and reduce adverse effects.

Purpose of the Study:

  • To explore the development of bone-targeting drug delivery systems using water-soluble polymers.
  • To investigate methods for enhancing drug specificity to bone tissue.
  • To reduce systemic toxicity associated with musculoskeletal disease treatments.

Main Methods:

  • Designing polymer carriers with specific targeting moieties for bone.
  • Incorporating controlled drug release mechanisms within the polymer system.

Related Experiment Videos

  • Optimizing polymer properties for efficient drug delivery to bone.

    • Main Results:

    • Bone-targeting systems demonstrate potential for specific drug localization to bone tissue.
    • Reduced non-specific tissue interactions are anticipated, leading to lower toxicity.
    • The development of macromolecular therapeutics for bone diseases is advanced.

    Conclusions:

    • Bone-targeting drug delivery systems offer a promising strategy for treating musculoskeletal diseases.
    • Specificity in drug delivery can significantly mitigate treatment-related side effects.
    • This approach holds potential for advancing the clinical application of novel therapeutics for bone conditions.